Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EMvision Medical Devices Ltd. ( (AU:EMV) ) has issued an update.
EMVision Medical Devices Ltd has announced that its Annual General Meeting (AGM) will be held on November 11, 2025, in Sydney. The meeting will include discussions on various resolutions, and nominations for director positions must be submitted by September 22, 2025. This announcement is part of the company’s ongoing efforts to engage with shareholders and stakeholders, reflecting its commitment to transparency and governance.
The most recent analyst rating on (AU:EMV) stock is a Buy with a A$2.95 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMVision Medical Devices Limited is an Australian company specializing in the development of innovative medical devices. Their primary focus is on creating portable, non-invasive, and affordable neurodiagnostic devices aimed at improving the timely diagnosis and treatment of strokes and other urgent medical conditions at the point-of-care.
Average Trading Volume: 38,593
Technical Sentiment Signal: Buy
Current Market Cap: A$198.4M
See more data about EMV stock on TipRanks’ Stock Analysis page.